Lisa Walter
Analyst
RBC Capital Markets
Analyst
RBC
Analyst
on for Luca Issi)
Equibles does not estimate personal net worth.
About Lisa Walter
Lisa Walter is recorded as Analyst at RBC Capital Markets, Analyst at RBC and Analyst at on for Luca Issi). Lisa Walter has spoken on 7 earnings calls and 5 other investor events across 8 companies, most recently for Viridian Therapeutics, Inc.\DE on November 4, 2026. Those appearances were for Mirum Pharmaceuticals, Inc. (MIRM), EyePoint, Inc. (EYPT), Viridian Therapeutics, Inc.\DE (VRDN), UNITED THERAPEUTICS Corp (UTHR), 4D Molecular Therapeutics, Inc. (FDMT) and 3 other companies. The companies whose calls Lisa Walter spoke on are classified in the Healthcare sector.
Lisa Walter on recent calls
“Can you give us an idea of how patient start forms are translating into patients on therapy? And can you share how many patients have received their second infusion?”
“Maybe just given the recent challenges with the FDA and PSC, just curious if the same group of regulators will also be reviewing your filings for biliary artresia as part of the EXPAND study, as well as a potential filing for PBC.”
“Just a quick one on the IPF SMDA filing. Wonder if you could share the date when it was filed and when we could hear about acceptance of the filing and whether you think there is potential for a priority review?”
“Kind of one more on the NDA filing delay here for the looks of that. Could this mean that we see more BD in the near term as potentially PSC revenues may now be pushed out?”
“This session, we have Miram Pharmaceuticals, and we have the pleasure of hosting Peter Radovich, President and COO, as well as Andrew McKibben, Senior VP, Strategic Finance and Investor Relations.”
Affiliation history
-
RBC Capital Markets
Analyst
Source not stated
Current -
RBC
Analyst
Source not stated
Current -
on for Luca Issi)
Analyst
Source not stated
Current
Company network
EYPT
Biotechnology · Healthcare
Drug Manufacturers - Specialty & Generic · Healthcare